DAFNA CAPITAL MANAGEMENT LLC – Mersana Therapeutics, Inc. Transaction History
DAFNA CAPITAL MANAGEMENT LLC portfolio value:
$2.55M
portfolio value
DAFNA CAPITAL MANAGEMENT LLC quarter portfolio value change:
+46.32%
quarter
Mersana Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -7.13% | -29K shares | 675K | $6.76 | 377.76K |
| Q2 2022 | share | Increase | +15.31% | 54K shares | 471K | $4.62 | 406.76K |
| Q1 2022 | share | Increase | +151.50% | 212.5K shares | 536K | $3.99 | 352.76K |
| Q4 2021 | share | 0.00% | 0 shares | -451K | $6.4 | 140.26K | |
| Q3 2021 | share | Increase | +9.36% | 12K shares | -419K | $9.43 | 140.26K |
| Q2 2021 | share | Increase | +3.22% | 4K shares | -269K | $13.58 | 128.26K |
| Q1 2021 | share | Increase | +152.24% | 75K shares | 700K | $16.18 | 124.26K |
| Q4 2020 | share | Decrease | -67.75% | -103.5K shares | -1.53M | $26.61 | 49.26K |
| Q3 2020 | share | Decrease | -43.46% | -117.4K shares | -3.47M | $18.62 | 152.76K |
| Q2 2020 | share | Decrease | -32.73% | -131.45K shares | 3.98M | $23.4 | 270.16K |
| Q1 2020 | share | Increase | +270.28% | 293.15K shares | 1.72M | $5.83 | 401.61K |
| Q4 2019 | share | Decrease | -78.38% | -393.27K shares | -172K | $5.73 | 108.46K |
| Q3 2019 | share | Increase | +82.29% | 226.5K shares | -322K | $1.58 | 501.73K |
| Q2 2019 | share | Decrease | -31.75% | -128.06K shares | -1.00M | $4.05 | 275.23K |
| Q1 2019 | share | Increase | 0.00% | 403.3K shares | 2.12M | $5.26 | 403.3K |